New strategies to target telomerase in liver cancer are being studied in vivo and in vitro and include small molecules inhibiting TERT enzymes, antisense oligonucleotides and molecules that stabilize the DNA G-quadruplex or block telomerase access to telomeres [143]. Here, TERT is linked to liver cancer.